Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries.

导出 LinkOut

翻译打印收藏纠错

作者： Urszula,Głowacka ^[1] ; Marcin,Magierowski ^[2] ; Zbigniew,Śliwowski ^[1] ; Jakub,Cieszkowski ^[1] ; Małgorzata,Szetela ^[1] ; Dagmara,Wójcik-Grzybek ^[1] ; Anna,Chmura ^[1] ; Tomasz,Brzozowski ^[1] ; John L,Wallace ^[1] ; Katarzyna,Magierowska ^[3]

作者单位： Department of Physiology, Jagiellonian University Medical College, 16 Grzegórzecka Street, 31-531 Kraków, Poland. ^[1] Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, 31-530 Kraków, Poland. ^[2] Department of Physiology and Pharmacology, University of Calgary, Calgary, AB T2N 1N4, Canada. ^[3]

关键词 ATB-344 gastric oxidative injury hydrogen sulfide indomethacin non-steroidal anti-inflammatory drugs

DOI 10.3390/antiox12081545

PMID 37627540

发布时间 2023-08-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Antioxidants (Basel, Switzerland)

2023年12卷8期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries.

Antioxidants (Basel, Switzerland)

相似文献

Antioxidants (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries.

Antioxidants (Basel, Switzerland)

相似文献

Antioxidants (Basel, Switzerland)

相关期刊

检索历史清除